-
European Spine Journal : Official... May 2013Cauda equina syndrome (CES) is a rare complication of lumbar disk herniation. Although micturition, defecation and/or sexual function are by definition affected, little... (Review)
Review
PURPOSE
Cauda equina syndrome (CES) is a rare complication of lumbar disk herniation. Although micturition, defecation and/or sexual function are by definition affected, little seems to be known about long-term outcome. Aim of this study is to review current literature on outcome of micturition, defecation and sexual function in CES due to lumbar disk herniation.
METHODS
A literature search was done in Pubmed, Embase and Web of Science using a sensitive search string combination. Studies were selected by predefined selection criteria and risk of bias was assessed using a Cochrane checklist adjusted for this purpose.
RESULTS
Fifteen studies were included. Risk of bias varied with six studies showing low risk. Mean minimal follow-up time was 17.0 months (range 3-24 months). All studies evaluated micturition and reported dysfunction at follow-up in 42.5% (range 13.3-90.0%). Defecation and sexual function were evaluated in eight and nine studies, respectively, and reported to be 49.6 (range 10.5-90.0%) and 44.3% (range 10.0-76.6%), respectively. Only two studies assessed sexual function in all patients at follow-up.
CONCLUSION
This review offers an insight into the extent of micturition dysfunction, defecation dysfunction and sexual dysfunction (SD) in CES after decompression. Our findings show that dysfunction is extremely common, even at long-term follow-up. A condition as invalidating as CES requires proper patient information and the outcomes presented here may help in providing those data. Bias in included studies, lack of universal definitions and incomplete follow-up results qualify these data as the best we momentarily have, but still subject to improvement. Since SD seems to be severely underreported, we recommend further research to explore the extent of this problem, as well as the use of questionnaires in future clinical (prospective) studies to accomplish a more patient-based approach.
Topics: Defecation; Humans; Intervertebral Disc Displacement; Lumbar Vertebrae; Polyradiculopathy; Rectal Diseases; Sexual Dysfunction, Physiological; Urination; Urination Disorders
PubMed: 23238848
DOI: 10.1007/s00586-012-2601-8 -
Medical Science Monitor : International... Aug 2012Ocular ischemic syndrome is a rare condition, which is caused by ocular hypoperfusion due to stenosis or occlusion of the common or internal carotid arteries.... (Review)
Review
Ocular ischemic syndrome is a rare condition, which is caused by ocular hypoperfusion due to stenosis or occlusion of the common or internal carotid arteries. Atherosclerosis is the major cause of changes in the carotid arteries. Ocular ischemic syndrome is manifested as visual loss, orbital pain and, frequently, changes of the visual field, and various anterior and posterior segment signs. Anterior segment signs include iris neovascularization and secondary neovascular glaucoma, iridocyclitis, asymmetric cataract, iris atrophy and sluggish reaction to light. Posterior eye segment changes are the most characteristic, such as narrowed retinal arteries, perifoveal telangiectasias, dilated retinal veins, mid-peripheral retinal hemorrhages, microaneurysms, neovascularization at the optic disk and in the retina, a cherry-red spot, cotton-wool spots, vitreous hemorrhage and normal-tension glaucoma. Differential diagnosis of ocular ischemic syndrome includes diabetic retinopathy and moderate central retinal vein occlusion. Carotid artery imaging and fundus fluorescein angiography help to establish the diagnosis of ocular ischemic syndrome. The treatment can be local, for example, ocular (conservative, laser and surgical) or systemic (conservative and surgical treatment of the carotid artery). Since the condition does not affect the eyes alone, patients with ocular ischemic syndrome should be referred for consultation to the neurologist, vascular surgeon and cardiologist.
Topics: Animals; Diagnosis, Differential; Eye; Eye Diseases; Humans; Ischemia; Syndrome
PubMed: 22847215
DOI: 10.12659/msm.883260 -
Acta Ophthalmologica Mar 2012A large number of methods have been developed for assessing glaucomatous visual field progression, but their properties have not yet been systematically evaluated. In... (Review)
Review
A large number of methods have been developed for assessing glaucomatous visual field progression, but their properties have not yet been systematically evaluated. In this systematic literature review, we summarize the evidence base for selecting a method by providing answers to ten relevant questions on the variety, validity and reproducibility of methods. In total, we found 301 different methods in 412 articles. The majority of studies (54%) used the Humphrey Field Analyzer. No data have been published about the reproducibility of methods. Although there is no gold standard to assess glaucomatous visual field progression, we found evidence on validity for 48 different methods. Some methods were less capable of distinguishing between progressive and nonprogressive patients. Choosing among twelve methods is supported by some evidence of their validity. These methods still differ in sensitivity, specificity and predictive values of test results within studies comparing several methods. In conclusion, the current evidence base is not perfect. A selection should be made from a limited number of methods, according to the clinical purpose of progression assessment. Methods that quantify the rate of visual field progression seem to be the most appropriate for guiding subsequent medical actions in individual patients. Future studies should investigate whether using one method to monitor patients is superior to another method in preventing loss of quality of life.
Topics: Diagnostic Techniques, Ophthalmological; Disease Progression; Evidence-Based Medicine; False Positive Reactions; Glaucoma, Open-Angle; Humans; Optic Disk; Optic Nerve Diseases; Predictive Value of Tests; Reproducibility of Results; Sensitivity and Specificity; Validation Studies as Topic; Vision Disorders; Visual Field Tests; Visual Fields
PubMed: 21812943
DOI: 10.1111/j.1755-3768.2011.02206.x -
The Cochrane Database of Systematic... May 2011Some sports, for example basketball and soccer, have a very high incidence of ankle injuries, mainly sprains. Consequently, ankle sprains are one of the most commonly... (Meta-Analysis)
Meta-Analysis Review
BACKGROUND
Some sports, for example basketball and soccer, have a very high incidence of ankle injuries, mainly sprains. Consequently, ankle sprains are one of the most commonly treated injuries in acute care.
OBJECTIVES
To assess the effects of interventions used for the prevention of ankle ligament injuries or sprains in physically active individuals from adolescence to middle age.
SEARCH STRATEGY
We searched the Cochrane Bone, Joint and Muscle Trauam Group's specialised register, MEDLINE, PubMed, EMBASE, CINAHL, the National Research Register and bibliographies of study reports. We also contacted colleagues and some trialists. The most recent search was conducted in July 2000.
SELECTION CRITERIA
Randomised or quasi-randomised trials of interventions for the prevention of ankle sprains in physically active individuals from adolescence to middle age were included provided that ankle sprains were recorded. Interventions included use of modified footwear, external ankle supports, co-ordination training and health education. These could be applied as a supplement to treatment provided that prevention of re-injury was the primary objective.
DATA COLLECTION AND ANALYSIS
At least two reviewers independently assessed methodological quality and extracted data. Wherever possible, results of outcome measures were pooled and sub-grouped by history of previous sprain. Relative risks (RR) and 95% confidence intervals (95% CI) are reported for individual and pooled data.
MAIN RESULTS
In this review update, a further nine new trials were included. Overall, 14 randomised trials with data for 8279 participants were included. Twelve trials involved active, predominantly young, adults participating in organised, generally high-risk, activities. The other two trials involved injured patients who had been active in sports before their injury. The prophylactic interventions under test included the application of an external ankle support in the form of a semi-rigid orthosis (three trials), air-cast brace (one trial) or high top shoes (one trial); ankle disk training; taping; muscle stretching; boot inserts; health education programme and controlled rehabilitation.The main finding was a significant reduction in the number of ankle sprains in people allocated external ankle support (RR 0.53, 95% CI 0.40 to 0.69). This reduction was greater for those with a previous history of ankle sprain, but still possible for those without prior sprain. There was no apparent difference in the severity of ankle sprains or any change to the incidence of other leg injuries. The protective effect of 'high-top' shoes remains to be established.There was limited evidence for reduction in ankle sprain for those with previous ankle sprains who did ankle disk training exercises. Various problems with data reporting limited the interpretation of the results for many of the other interventions.
AUTHORS' CONCLUSIONS
This review provides good evidence for the beneficial effect of ankle supports in the form of semi-rigid orthoses or air-cast braces to prevent ankle sprains during high-risk sporting activities (e.g. soccer, basketball). Participants with a history of previous sprain can be advised that wearing such supports may reduce the risk of incurring a future sprain. However, any potential prophylactic effect should be balanced against the baseline risk of the activity, the supply and cost of the particular device, and for some, the possible or perceived loss of performance.Further research is indicated principally to investigate other prophylactic interventions, their cost-effectiveness and general applicability.
Topics: Adolescent; Adult; Affective Symptoms; Age Factors; Child; Cohort Studies; Female; Humans; Infant; Infant, Newborn; Longitudinal Studies; Male; Maternal Deprivation; New York; Object Attachment; Personality Development; Prospective Studies; Risk Factors; Schizotypal Personality Disorder
PubMed: 21563126
DOI: 10.1002/14651858.CD000018.pub2 -
Cranio : the Journal of... Jul 2010Hyaluronate acid (HA) injections are gaining attention as a treatment option to manage symptoms of temporomandibular joint (TMJ) disorders, but updated evidence-based... (Review)
Review
Hyaluronate acid (HA) injections are gaining attention as a treatment option to manage symptoms of temporomandibular joint (TMJ) disorders, but updated evidence-based data on their effectiveness are actually lacking. The present paper aims to summarize and review systematically the clinical studies on the use of hyaluronic acid injections to treat TMJ disorders performed over the last decade. On November 9, 2009, a systematic search in the National Library of Medicine's PubMed (http://www.ncbi.nlm.nih.gov/pubmed) database was performed by means of a combined MeSH and word terms to identify all peer-reviewed papers published in the English literature dealing with the hyaluronic acid infiltration in patients affected by TMJ disorders. The selected papers were assessed according to a structured reading of articles format, which provided that the study design was methodologically evaluated in relation to four main issues, viz., population, intervention, comparison, and outcome. Nineteen (N=19) papers were selected for inclusion in the review, twelve (N=12) dealt with the use of hyaluronic acid in TMJ disk displacements and seven (N=7) dealt with inflammatory-degenerative disorders. Only nine groups of researchers were involved in the studies, and less than half of the studies (8/19) were randomized and controlled trials (RCTs). All studies reported a decrease in pain levels independently by the patients' disorder and by the adopted injection protocol. Positive outcomes were maintained over the follow-up period, which was varied among studies, ranging between 15 days and 24 months. The superiority of HA injections was shown only against placebo saline injections, but outcomes are comparable with those achieved with corticosteroid injections or oral appliances. The available literature seems to be inconclusive as to the effectiveness of HA injections with respect to other therapeutic modalities in treating TMJ disorders. Studies with a better methodological design are needed to gain better insight into this issue and to draw clinically useful information on the most suitable protocols for each different TMJ disorder.
Topics: Humans; Hyaluronic Acid; Injections, Intra-Articular; Joint Dislocations; Osteoarthritis; Temporomandibular Joint Disorders; Treatment Outcome; Viscosupplements
PubMed: 20806734
DOI: 10.1179/crn.2010.023 -
SAS Journal 2008This study is a systematic review of published biomechanical studies involving pedicle screw-based posterior dynamic stabilization devices (PDS) with a special focus on...
STUDY DESIGN
This study is a systematic review of published biomechanical studies involving pedicle screw-based posterior dynamic stabilization devices (PDS) with a special focus on kinematics and load transmission through the functional spine unit (FSU).
METHODS
A literature search was performed via the PubMed online database from 1990 to 2008 using the following key words: "biomechanics," "lumbar dynamic stabilization," "Graf system," "Dynesys," and "posterior dynamic implant." Citations were limited to papers describing biomechanics of pedicle screw-based PDS devices currently available for clinical use. Studies describing clinical experience, radiology, and in vivo testing were excluded from the review. Parameters measured included kinematics of the FSU (range of motion (ROM), neutral zone (NZ), and location of the center of rotation) and load transmission through the disk, facets, and instrumentation.
RESULTS
A total of 27 publications were found that concerned the biomechanical evaluation of lumbar pedicle screw-based dynamic stabilization instrumentation. Nine in vitro experimental studies and 4 finite element analyses satisfied the inclusion criteria. The Dynesys implant was the most investigated pedicle screw-based PDS system. In vitro cadaveric studies mainly focused on kinematics comparing ROM of intact versus instrumented spines whereas finite element analyses allowed analysis of load transmission at the instrumented and adjacent levels.
CONCLUSION
Biomechanical studies demonstrate that pedicle screw-based PDS devices limit intervertebral motion while unloading the intervertebral disk. The implant design and the surgical technique have a significant impact on the biomechanical behavior of the instrumented spinal segment. The posterior placement of such devices results in non-physiologic intervertebral kinematics with a posterior shift of the axis of rotation. Biomechanical studies suggest that the difference at the adjacent level between investigated dynamic devices and rigid stabilization systems may not be as high as reported. Finally, additional investigations of semirigid devices are needed to further evaluate their biomechanical properties compared to soft stabilization PDS systems.
PubMed: 25802618
DOI: 10.1016/SASJ-2008-0010-LR -
The Cochrane Database of Systematic... Apr 2007Mortality and morbidity from acute myocardial infarction (AMI) remain high. Intravenous magnesium started early after the onset of AMI is thought to be a promising... (Meta-Analysis)
Meta-Analysis Review
BACKGROUND
Mortality and morbidity from acute myocardial infarction (AMI) remain high. Intravenous magnesium started early after the onset of AMI is thought to be a promising adjuvant treatment. Conflicting results from earlier trials and meta-analyses warrant a systematic review of available evidence.
OBJECTIVES
To examine the effect of intravenous magnesium versus placebo on early mortality and morbidity.
SEARCH STRATEGY
We searched CENTRAL (The Cochrane Library Issue 3, 2006), MEDLINE (January 1966 to June 2006) and EMBASE (January 1980 to June 2006), and the Chinese Biomedical Disk (CBM disk) (January 1978 to June 2006). Some core Chinese medical journals relevant to the cardiovascular field were hand searched from their starting date to the first-half year of 2006.
SELECTION CRITERIA
All randomized controlled trials that compared intravenous magnesium with placebo in the presence or absence of fibrinolytic therapy in addition to routine treatment were eligible if they reported mortality and morbidity within 35 days of AMI onset.
DATA COLLECTION AND ANALYSIS
Two reviewers independently assessed the trial quality and extracted data using a standard form. Odds ratio (OR) were used to pool the effect if appropriate. Where heterogeneity of effects was found, clinical and methodological sources of this were explored.
MAIN RESULTS
For early mortality where there was evidence of heterogeneity, a fixed-effect meta-analysis showed no difference between magnesium and placebo groups (OR 0.99, 95%CI 0.94 to 1.04), while a random-effects meta-analysis showed a significant reduction comparing magnesium with placebo (OR 0.66, 95% CI 0.53 to 0.82). Stratification by timing of treatment (< 6 hrs, 6+ hrs) reduced heterogeneity, and in both fixed-effect and random-effects models no significant effect of magnesium was found. In stratified analyses, early mortality was reduced for patients not treated with thrombolysis (OR=0.73, 95% CI 0.56 to 0.94 by random-effects model) and for those treated with less than 75 mmol of magnesium (OR=0.59, 95% CI 0.49 to 0.70) in the magnesium compared with placebo groups.Meta-analysis for the secondary outcomes where there was no evidence of heterogeneity showed reductions in the odds of ventricular fibrillation (OR=0.88, 95% CI 0.81 to 0.96), but increases in the odds of profound hypotension (OR=1.13, 95% CI 1.09 to 1.19) and bradycardia (OR=1.49, 95% CI 1.26 to 1.77) comparing magnesium with placebo. No difference was observed for heart block (OR=1.05, 95% CI 0.97-1.14). For those outcomes where there was evidence of heterogeneity, meta-analysis with both fixed-effect and random-effects models showed that magnesium could decrease ventricular tachycardia (OR=0.45, 95% CI 0.31 to 0.66 by fixed-effect model; OR=0.40, 95% CI 0.19 to 0.84 by random-effects model) and severe arrhythmia needing treatment or Lown 2-5 (OR=0.72, 95% CI 0.60 to 0.85 by fixed-effect model; OR=0.51, 95% CI 0.33 to 0.79 by random-effects model) compared with placebo. There was no difference on the effect of cardiogenic shock between the two groups.
AUTHORS' CONCLUSIONS
Owing to the likelihood of publication bias and marked heterogeneity of treatment effects, it is essential that the findings are interpreted cautiously. From the evidence reviewed here, we consider that: (1) it is unlikely that magnesium is beneficial in reducing mortality both in patients treated early and in patients treated late, and in patients already receiving thrombolytic therapy; (2) it is unlikely that magnesium will reduce mortality when used at high dose (>=75 mmol); (3) magnesium treatment may reduce the incidence of ventricular fibrillation, ventricular tachycardia, severe arrhythmia needing treatment or Lown 2-5, but it may increase the incidence of profound hypotension, bradycardia and flushing; and (4) the areas of uncertainty regarding the effect of magnesium on mortality remain the effect of low dose treatment (< 75 mmol) and in patients not treated with thrombolysis.
Topics: Aspartic Acid; Humans; Injections, Intravenous; Magnesium Chloride; Magnesium Compounds; Magnesium Sulfate; Myocardial Infarction; Randomized Controlled Trials as Topic
PubMed: 17443517
DOI: 10.1002/14651858.CD002755.pub2 -
Reumatologia Clinica May 2006To perform a systematic review to analyze the efficacy on which the use of ozone therapy in musculoskeletal diseases is based.
OBJECTIVE
To perform a systematic review to analyze the efficacy on which the use of ozone therapy in musculoskeletal diseases is based.
METHODS
A literature search was performed in PubMed, Embase and the Cochrane Library using highly sensitive search terms to identify all studies on ozone therapy. All studies showing the efficacy or effectiveness of ozone therapy in any musculoskeletal disease were selected.
RESULTS
Only 6 relevant studies were identified, 5 in lumbar disk herniation and 1 in Raynaud's syndrome. Of the 5 studies in disk herniation, only 3 were clinical trials and none used random allocation. Study participants were generally patients with symptomatic small discal hernias. There was wide variability in the dose of ozone injected as well as in the controls used for comparison. All outcome measures were subjective and there was no blinded evaluation of the results. The study in Raynaud's syndrome included only 4 patients. Adverse effects were not evaluated in detail.
CONCLUSIONS
The use of ozone therapy in musculoskeletal diseases is based on poor quality studies. Currently, data supporting an adequate risk/benefit ratio for ozone therapy in rheumatic diseases is lacking.
PubMed: 21794314
DOI: 10.1016/S1699-258X(06)73032-7 -
The Angle Orthodontist Feb 2003The purpose of this systematic review was to evaluate the effect of bilateral sagittal split mandibular osteotomy (BSSO) with rigid internal fixation (RIF) on... (Meta-Analysis)
Meta-Analysis
The purpose of this systematic review was to evaluate the effect of bilateral sagittal split mandibular osteotomy (BSSO) with rigid internal fixation (RIF) on temporomandibular joint (TMJ) morphology. Controlled trials of BSSO with RIF treatment of Class II patients using transcranial radiographs, submental vertex (SMV) radiographs, tomographic radiography, computed tomography (CT) scan, or magnetic resonance imaging (MRI) to assess TMJ morphology were identified by Medline (1966-2001) and PubMed. Case reports were excluded. On the basis of our search only six studies were included in this review. All studies used internal controls with pre- and posttreatment imaging. Two studies used SMV, one used transcranial radiographs, one used tomography, two used CT scan and one used MRI. Methodological deficiencies prevent major conclusions regarding osseous remodeling and disk status. There was a wide range of individual variability in condyle position change. The reviewed studies have highlighted the importance of further research. Prospective controlled studies using serial MRI and tomography or CT scan are required to establish effect of BSSO with RIF on TMJ morphology.
Topics: Adult; Bone Remodeling; Controlled Clinical Trials as Topic; Female; Humans; Internal Fixators; Magnetic Resonance Imaging; Male; Malocclusion, Angle Class II; Mandible; Mandibular Advancement; Mandibular Condyle; Orthopedic Fixation Devices; Osteotomy; Prospective Studies; Temporomandibular Joint; Temporomandibular Joint Disc; Tomography, X-Ray; Tomography, X-Ray Computed
PubMed: 12607859
DOI: 10.1043/0003-3219(2003)073<0079:TJMCWM>2.0.CO;2